Evaluation and floating enhancement of levodopa sustained release floating minitablets coated with insoluble acrylic polymer

Drug Development and Industrial Pharmacy

Volumn 34, Issue 8, 2008, Pages 827-833

  Goole, J ^a   Amighi, K ^a   Vanderbist, F ^b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b Laboratoires SMB SA   (Belgium)

Author keywords

Coating; Eudragit ; Floating; Levodopa; Minitablets; Multiple unit system; RL30D; Sustained release

Indexed keywords

ACETYL TRIETHYCITRATE; EUDRAGIT; GLYCEROL PALMITOSTEARATE; LEVODOPA; PLASTICIZER; POLYACRYLIC ACID; TARTARIC ACID; UNCLASSIFIED DRUG;

ARTICLE; DISSOLUTION; DRUG CAPSULE; DRUG COATING; DRUG RELEASE; DRUG SOLUBILITY; FILM COATING; PH; SOLUBILITY; SUSTAINED DRUG RELEASE; TABLET COMPRESSION;

CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DOPAMINE AGENTS; HYDROGEN-ION CONCENTRATION; LEVODOPA; POLYMETHACRYLIC ACIDS; TABLETS, ENTERIC-COATED;

EID: 49449104929     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040801926683     Document Type: Article

References (29)

1. Amighi, K., & Moës, A. J. (1995). Evaluation of thermal and film forming properties of acrylic aqueous polymer dispersion blends: Application to the formulation of sustained-release film coated theophylline pellets. Drug Dev. Ind. Pharm., 21, 2355-2369.
2. Amighi, K., & Moës, A. J. (1997). Influence of curing conditions on the drug release rate from eudragit NE30D film coated sustained-release theophylline pellets. S.T.P. Pharma. Sci., 7, 141-147.
3. Baumgartner, S., Kristl, J., Vrecer, F., Vodopivec, P., & Zorko, B. (2000). Optimisation of floating matrix tablets and evaluation of their gastric residence time. Int. J. Pharm., 195, 125-135.
4. Clarke, E. G. C. (1986) Clarke's Isolation and Identification of Drugs in Pharmaceuticals Body Fluids and Post-Mortem Material (2nd ed.). London: The Pharmaceutical Press.
5. Deshpande, A. A., Rhodes, C. T., Shah, N. H., & Malick, A. W. (1996). Controlled-release drug delivery systems for prolonged gastric residence: An overview. Drug Dev. Ind. Pharm., 22(6), 531-539.
6. Dressman, J. B., Amidon, G. L., Reppas, C., & Shah, V. P. (1998). Dissolution testing as a prognostic tool for oral drug absorption: Immediate release dosage forms. Pharm. Res., 15, 11-22.
7. Fukunaka, T., Yaegashi, Y., Nunoko, T., Ito, R., Golman, B., & Shinohara, K. (2006). Dissolution characteristics of cylindrical particles and tablets. Int. J. Pharm., 310, 146-153.
8. Goole, J., Vanderbist, F., & Amighi, K. (2007). Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms. Int. J. Pharm., 334, 35-41.
9. Goole, J., Deleuze, Ph., Vanderbist, F., & Amighi, K. (2008). New levodopa sustained-release floating minitablets coated with insoluble acrylic polymer. Eur. J. Pharm. Biopharm., 68, 310-318.
10. Guidance for Industry (FDA). (September 1997). Extended Release Oral Dosage Form: Development Evaluation, and Application of In Vitro/In Vivo Correlations. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research.
11. Gutiérrez-Rocca, J. C., & McGinity, J. W. (1994). Influence of water soluble and insoluble plasticizers on the physical and mechanical properties of acrylic resin copolymers. Int. J. Pharm., 103, 293-301.
12. Hamdani, J., Moës, A. J., & Amighi, K. (2002). Development and evaluation of prolonged release pellets obtained by the melt pelletization process. Int. J. Pharm., 245, 167-177.
13. Hamdani, J., Moës, A. J., & Amighi, K. (2006). Development and in vitro evaluation of a novel floating multiple unit dosage form obtained by melt pelletization. Int. J. Pharm., 322, 96-103.
14. Hoffman, A., Stepensky, D., Lavy, E., Eyal, S., Klausner, E., & Friedman, M. (2004). Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms. Int. J. Pharm., 277, 141-153.
15. Iannuccelli, V., Coppi, G., Bernabei, M. T., & Cameroni, R. (1998a). Air compartment multiple-unit system for prolonged gastric residence. Part I. Formulation study. Int. J. Pharm., 174, 47-54.
16. Iannuccelli, V., Coppi, G., Bernabei, M. T., & Cameroni R (1998b). Air compartment multiple-unit system for prolonged gastric residence. Part II. In vivo evaluation. Int. J. Pharm., 174, 55-62.
17. Ichikawa, M., Watanabe, S., & Miyake, Y. (1991). A new multiple-unit oral floating dosage system. I. Preparation and in vitro evaluation of floating and sustained-release characteristics. J. Pharm. Sci., 80, 1062-1066.
18. Kamba, M., Seta, Y. S., Kusai, A., Ikeda, M., & Nishimura, K. (2000). A unique dosage form to evaluate the mechanical destructive force in the gastrointestinal tract. Int. J. Pharm., 208, 61-70.
19. Katori, N., Aoyagi, N., & Terao, T. (1995). Estimation of agitation intensity in the GI tract in humans and dogs based on in vitro/in vivo correlation. Pharm. Res., 12, 237-243.
20. Moës, A. J. (1993). Gastroretentive dosage forms. Crit. Rev. Ther. Drug Carrier Syst., 10, 143-195.
21. Rouge, N., Buri, P., & Doelker, E. (1996). Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. Int. J. Pharm., 136, 386-339.
22. Russel, T. L., Berardi, R. R., Barnett, J. L., Dermentzoglou, L. C., Jarvenpaa, K. M., Schmaltz, S. P., & Dressman, J. B. (1993). Upper gastrointestinal pH in seventy-nine healthy, elderly, north American men and women. Pharm. Res., 10, 187-196.
23. Sato, Y., Kawashima, Y., Takeuchi, H., & Yamamoto, H. (2004). In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans. Int. J. Pharm., 275, 97-107.
24. 2. Pharm. Res., 15, 889-896.
25. Streubel, A., Siepmann, J., & Bodmeier, R. (2003). Floating matrix tablets based on low density foam powder: Effects of formulation and processing parameters on drug release. Eur. J. Pharm. Sci., 18, 37-45.
26. Sungthongjeen, S., Paeratakul, O., Limmatvapirat, S., & Puttipipatkhachorn, S. (2006). Preparation and in vitro evaluation of a multiple-unit floating drug delivery system based on gas formation technique. Int. J. Pharm., 324, 136-143.
27. Timmermans, J., & Moës, A. J. (1990). Measuring the resultant-weight of an immersed test material. I. Validation of an apparatus and a method dedicated to pharmaceutical applications. Acta Pharm. Technol., 36, 171-175.
28. Whitehead, L., Fell, J. T., Collett, J. H., Sharma, H. L., & Smith, A. M. (1998). Floating dosage forms: An in vivo study demonstrating prolonged gastric retention. J. Control. Release, 55, 3-12.
29. Xiaoqiang, X., Minjie, S., Feng, Z., & Yiqiao, H. (2006). Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: In vitro and in vivo evaluation in healthy volunteers. Int. J. Pharm., 310, 139-145.